Please use this identifier to cite or link to this item:
https://doi.org/10.3390/cells9030601
| Title: | Immunotherapy in Multiple Myeloma | Authors: | Soekojo, Cinnie Yentia Ooi, Melissa de Mel, Sanjay Chng, Wee Joo |
Keywords: | Science & Technology Life Sciences & Biomedicine Cell Biology multiple myeloma immunotherapy IMiD monoclonal antibody ADC BiTE checkpoint inhibitor CAR-T virotherapy vaccine STEM-CELL TRANSPLANTATION VESICULAR STOMATITIS-VIRUS LOW-DOSE DEXAMETHASONE NATURAL-KILLER-CELLS T-CELLS OPEN-LABEL MONOCLONAL-ANTIBODY DARATUMUMAB MONOTHERAPY CD38 EXPRESSION DENDRITIC CELLS |
Issue Date: | 1-Mar-2020 | Publisher: | MDPI | Citation: | Soekojo, Cinnie Yentia, Ooi, Melissa, de Mel, Sanjay, Chng, Wee Joo (2020-03-01). Immunotherapy in Multiple Myeloma. CELLS 9 (3). ScholarBank@NUS Repository. https://doi.org/10.3390/cells9030601 | Abstract: | Multiple myeloma is a complex disease and immune dysfunction has been known to play an important role in the disease pathogenesis, progression, and drug resistance. Recent efforts in drug development have been focused on immunotherapies to modify the MM disease process. Here, we summarize the emerging immunotherapies in the MM treatment landscape. | Source Title: | CELLS | URI: | https://scholarbank.nus.edu.sg/handle/10635/229006 | ISSN: | 20734409 | DOI: | 10.3390/cells9030601 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Immunotherapy in Multiple Myeloma. .pdf | Published version | 1.06 MB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.